Email This Press Releases

NASDAQ:BMRN Investor Notice: Lawsuit Alleges Securities Laws Violations by BioMarin Pharmaceutical Inc.

An investor, who purchased shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), filed a lawsuit over alleged Securities Laws violations by BioMarin Pharmaceutical Inc.

View full press release

  • We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy